| # | Drug | Count |
|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 447 |
| 1 | LIRAGLUTIDE | 38 |
| 2 | DULAGLUTIDE | 31 |
| 3 | TIRZEPATIDE | 30 |
| 4 | ONDANSETRON HYDROCHLORIDE | 21 |
| 5 | ADALIMUMAB | 20 |
| 6 | ONDANSETRON | 20 |
| 7 | PREGABALIN | 19 |
| 8 | ERGOCALCIFEROL | 16 |
| 9 | LORAZEPAM | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFENOQUINE | 1 | 0.0152 |
| 1 | OMALIZUMAB-IGEC | 1 | 0.0112 |
| 2 | ORAL SEMAGLUTIDE | 447 | 0.0057 |
| 3 | DELGOCITINIB | 1 | 0.0037 |
| 4 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 5 | ESTRADIOL CYPIONATE | 1 | 0.0017 |
| 6 | METHYLERGONOVINE MALEATE | 1 | 0.0016 |
| 7 | CYCLOPENTOLATE HYDROCHLORIDE | 1 | 0.0015 |
| 8 | VALERIAN | 1 | 0.0014 |
| 9 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 10 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 463 |
| 1 | Benzodiazepine [EPC] | 33 |
| 2 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 30 |
| 3 | Serotonin-3 Receptor Antagonist [EPC] | 21 |
| 4 | Atypical Antipsychotic [EPC] | 19 |
| 5 | Proton Pump Inhibitor [EPC] | 17 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 7 | Provitamin D2 Compound [EPC] | 16 |
| 8 | Opioid Agonist [EPC] | 15 |
| 9 | Corticosteroid [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 463 | 0.0010 |
| 1 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 2 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 3 | 0.0004 |
| 6 | Tetracycline-class Antibacterial [EPC] | 3 | 0.0004 |
| 7 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 8 | Antisense Oligonucleotide [EPC] | 3 | 0.0003 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |